SCHEMBL6161912

SCHEMBL6161912

CCOC(C)=NC(=O)c1cccc(OC)c1.COc1cccc(-c2nc(C)nn2-c2ccc(S(N)(=O)=O)cc2)c1

nearest known ligand 0.49

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
CA1 P00915 8/20 0.49
CA2 P00918 8/20 0.49
CA9 Q16790 3/20 0.49
CA7 P43166 7/20 0.46
CA4 P22748 6/20 0.46
PTGS2 P35354 7/20 0.46
CYP1A2 P05177 1/20 0.43
CYP3A4 P08684 1/20 0.43
CYP2D6 P10635 1/20 0.43
CYP2C9 P11712 1/20 0.43
CYP2B6 P20813 1/20 0.43
PTGS1 P23219 1/20 0.42
KDR P35968 1/20 0.42
CA12 O43570 1/20 0.42
CA14 Q9ULX7 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6169232 0.88 CHRNA7 (0.45) CA1CA2CA9CA7CA4
SCHEMBL5203044 0.83 CA2 (0.61) CA1CA2CA9CA7CA4
SCHEMBL6171769 0.80 CHRNA7 (0.53) CA1CA2CA9CA7CA4
SCHEMBL6172783 0.78 CHRNA7 (0.41) CA1CA2CA9CA7CA4
SCHEMBL6174360 0.78 CSNK1D (0.39) CA1CA2CA9CA7CA4
SCHEMBL6172080 0.75 CA9 (0.42) CA1CA2CA9CA7CA4
SCHEMBL6172900 0.75 CA9 (0.47) CA1CA2CA9CA7CA4
SCHEMBL5203413 0.75 NPC1 (0.53)
SCHEMBL5203419 0.75 NPC1 (0.53)
SCHEMBL5202701 0.74 CA1 (0.53) CA1CA2CA9CA7CA4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1458706-A4 DIARYL 1,2,4-TRIAZOLE DERIVATIVES AS A HIGHLY SELECTIVE CYCLOOXYGENASE-2 INHIBITOR CJ CORP (KR) 2005-06-08 EP disclosed
EP-1458706-A1 DIARYL 1,2,4-TRIAZOLE DERIVATIVES AS A HIGHLY SELECTIVE CYCLOOXYGENASE-2 INHIBITOR CJ Corp. (KR) 2004-09-22 EP disclosed
WO-2003055875-A1 DIARYL 1,2,4-TRIAZOLE DERIVATIVES AS A HIGHLY SELECTIVE CYCLOOXYGENASE-2 INHIBITOR CJ CORP. (KR) 2003-07-10 WO disclosed